Mesa Laboratories, Inc.
Rank #150HypergrowthMLAB · Nasdaq · Technology
Mesa Laboratories, Inc. (MLAB) — Rank #150 by gross profitability (GP/assets 0.38) · ROE 3.6% · Piotroski F-Score 6 / 9.
As-of 2026-09-15 · CIK 0000724004 · all metrics point-in-time as of the filing date.
About
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
Show moreShow less
The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc.
was incorporated in 1982 and is headquartered in Lakewood, Colorado.
- Industry
- Scientific & Technical Instruments
- Sector
- Technology
- State
- CO
- Filer Category
- Accelerated filer
- Fiscal Year End
- March 31
- Website
- mesalabs.com
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2023-03-31filed 2023-05-30 | 2022-03-31filed 2022-05-31 | 2021-03-31filed 2021-06-01 | 2020-03-31filed 2020-06-01 |
|---|---|---|---|---|
| Operating | ||||
| Depreciation & amortization | 33.8 | 25.1 | 17.7 | 13.0 |
| Stock-based compensation | 12.5 | 11.4 | 9.3 | 5.5 |
| Change in receivables | 2.1 | 6.8 | 0.6 | 1.7 |
| Change in inventory | 10.2 | 1.0 | (0.9) | (0.4) |
| Change in payables | (1.5) | 1.4 | 1.0 | (0.1) |
| Operating cash flow | 28.0 | 39.2 | 37.1 | 26.6 |
| Investing | ||||
| Capital expenditures | 4.5 | 4.4 | 2.0 | 1.5 |
| Acquisitions, net of cash | 5.0 | 300.8 | 0.0 | 184.1 |
| Investing cash flow | (9.5) | (305.2) | (2.0) | (185.6) |
| Financing | ||||
| Debt repaid | 36.0 | 21.0 | 0.0 | 23.0 |
| Dividends paid | 3.4 | 3.3 | 3.2 | 2.7 |
| Financing cash flow | (33.3) | 52.6 | 146.2 | 231.3 |
| Summary | ||||
| Free cash flow | 23.4 | 34.8 | 35.1 | 25.1 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?